Alexander Martin, MD
Urology · McKinney, TXNPI 1316504236
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,616 of the $3,255 with a category attached, or 80.4%. 23 manufacturers reported payments, led by Procept Biorobotics Corporation at 31.1% of the total. 2025 is the largest year on record at $2,120, more than ten times the $56 reported in 2023. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 81 payments — averaging $40.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$1K
- Teleflex LLC$666
- Agiliti Surgical, Inc.$443
- Calyxo, Inc.$250
- Tolmar, Inc.$152
- Sumitomo Pharma America, Inc.$116
- plus $616 from 17 others
What the payments were for
- Travel & lodging$63820%
- Food & beverage$2,61680%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 13 | $1,012 |
| Teleflex LLC | 8 | $666 |
| Agiliti Surgical, Inc. | 6 | $443 |
| Calyxo, Inc. | 6 | $250 |
| Tolmar, Inc. | 14 | $152 |
| Sumitomo Pharma America, Inc. | 5 | $116 |
| Boston Scientific | 5 | $98 |
| AbbVie | 3 | $68 |
| Accord Healthcare, Inc. | 3 | $61 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Endo USA, Inc. | 2 | $46 |
| Johnson & Johnson | 2 | $45 |
| Verity Pharmaceuticals Inc. | 2 | $33 |
| Ambu Inc. | 1 | $31 |
| Medtronic | 1 | $25 |
| Merck | 1 | $25 |
| Bayer | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $22 |
| Civco Medical Instruments | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $16 |
| Coloplast | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,255 in reported general payments places this provider in the 45th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other urology in McKinney
- Esther HanMcKinney$94K
- Brian CeballosMcKinney$57K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
- Daniel SaltzsteinSan Antonio$547K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.